GILD

Gilead Sciences, Inc. (GILD)

Last Price$88.4(4.0%)
Market Cap$95.9B
LTM Revenue
$28.3B
YoY Growth
+3.3%
3Y CAGR
+1.0%
5Y CAGR
+4.8%
Stock quality & Intrinsic value
6/10
46.5% overvalued

Gilead Sciences, Inc. Revenue

Annual
Quarterly
LTM
Crunching data... Almost there!
Dec'04Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
Revenue
$1,324.6M
$2,028.4M
$3,026.1M
$4,230.0M
$5,335.8M
$7,011.4M
$7,949.4M
$8,385.4M
$9,702.5M
$11.2B
$24.9B
$32.6B
$30.4B
$26.1B
$22.1B
$22.4B
$24.7B
$27.3B
$27.3B
$27.1B
See the GILD
full fundamental analysis
View -->
Overvalued or undervalued?
Check the intrinsic value for GILD
Explore -->

Gilead Sciences, Inc. (GILD) Revenue comparison analysis

Crunching data... Almost there!

Discover more Stock Ideas

Loved by
investors
worldwide
10K+
Investors use our platform
#1
Top value investing hub with all necessary tools
1K+
Experienced investors in our community
4.9
Average rating across all rating platforms

FAQ

1) What is Gilead Sciences, Inc.'s Revenue?

As of today, Gilead Sciences, Inc.'s last 12-month Revenue is $28.3B, based on the financial report for Sep 30, 2024 (Q3 2024).

2) What is Gilead Sciences, Inc.'s Revenue growth rate?

Over the last year, Gilead Sciences, Inc.'s Revenue growth was 3.3%. The average annual Revenue growth rates for Gilead Sciences, Inc. have been 3.4% over the past three years, 4.8% over the past five years.

3) Is Gilead Sciences, Inc.'s Revenue growth rate Good?

Over the last year, Gilead Sciences, Inc.'s Revenue growth was 3.3%, which is higher than industry growth of 0.1%. It indicates that Gilead Sciences, Inc.'s Revenue growth is Good.

4) How does Gilead Sciences, Inc.'s Revenue growth rate compare to its peers?

Over the last year, Gilead Sciences, Inc.'s Revenue growth was 3.3%, which is lower than peer median growth of 5.6%. The list of peers includes JNJ, SNY, MRK, PFE, ABBV, AZN, NVS, BMY, LLY, AMGN etc.